Long-term mortality, remission, criminality and psychiatric comorbidity of heroin dependence: 11-year findings from the Australian treatment outcome study

Addiction

Volumn 110, Issue 6, 2015, Pages 986-993

  Teesson, Maree ^a,b   Marel, Christina ^a,b   Darke, Shane ^a   Ross, Joanne ^a,b   Slade, Tim ^a,b   Burns, Lucy ^a   Lynskey, Michael ^c   Memedovic, Sonja ^a,b   White, Joanne ^a,b   Mills, Katherine L ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cohort; Criminality; Heroin; Longitudinal; Mortality; Psychiatric comorbidity

Indexed keywords

DIAMORPHINE;

ADULT; COHORT ANALYSIS; COMPLICATION; CRIME; DRUG OVERDOSE; FEMALE; FOLLOW UP; HEROIN DEPENDENCE; HUMAN; MAJOR DEPRESSION; MALE; MENTAL HEALTH; MORTALITY; NEEDLE SHARING; NEW SOUTH WALES; PERSONALITY DISORDER; PSYCHIATRIC DIAGNOSIS; SEX RATIO; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; TREATMENT OUTCOME;

ADULT; COHORT STUDIES; CRIME; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DUAL (PSYCHIATRY); DRUG OVERDOSE; FEMALE; FOLLOW-UP STUDIES; HEROIN; HEROIN DEPENDENCE; HUMANS; MALE; MENTAL HEALTH; NEEDLE SHARING; NEW SOUTH WALES; PERSONALITY DISORDERS; SEX DISTRIBUTION; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT OUTCOME;

EID: 84929132188     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12860     Document Type: Article

References (29)

1. Degenhardt L., Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012; 379: 55-70.
2. Darke S., Mills K. L., Ross J., Teesson M. Rates and correlates of mortality amongst heroin users: findings from the Australian Treatment Outcome Study (ATOS), 2001-2009. Drug Alcohol Depend 2011; 115: 190-5.
3. Darke S. The Life of the Heroin User: Typical Beginnings, Trajectories and Outcomes. Cambridge: Cambridge University Press; 2011.
4. United Nations Office on Drugs and Crime. World Illicit Drug Report. New York: United Nations Publications; 2004.
5. Stoove M. A., Dietze P. M., Aitken C. K., Jolley D. Mortality among injecting drug users in Melbourne: a 16-year follow-up of the Victorian Injecting Cohort Study (VICS). Drug Alcohol Depend 2008; 96: 281-5.
6. Degenhardt L., Bucello C., Mathers B., Briegleb C., Ali H., Hickman M. et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction 2011; 106: 32-51.
7. Grella C. E., Lovinger K. 30-year trajectories of heroin and other drug use among men and women sampled from methadone treatment in California. Drug Alcohol Depend 2011; 118: 251-8.
8. Gossop M., Stewart D., Marsden J. Attendance at Narcotics Anonymous and Alcoholics Anonymous meetings, frequency of attendance and substance use outcomes after residential treatment for drug dependence: a 5-year follow-up study. Addiction 2008; 103: 119-25.
9. Hser Y. I., Huang D., Chou C. P., Anglin M. D. Trajectories of heroin addiction: growth mixture modeling results based on a 33-year follow-up study. Eval Rev 2007; 31: 548-63.
10. Teesson M., Mills K., Ross J., Darke S., Williamson A., Havard A. The impact of treatment on 3years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Addiction 2008; 103: 80-8.
11. Ross J., Teesson M., Darke S., Lynskey M., Ali R., Ritter A. et al. The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS). Drug Alcohol Rev 2005; 24: 411-18.
12. Darke S., Ross J., Teesson M., Ali R., Cooke R., Ritter A. et al. Factors associated with 12months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS). J Subst Abuse Treat 2005; 28: 255-63.
13. Darke S., Hall W., Wodak A., Heather N., Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br J Addict 1992; 87: 733-42.
14. World Health Organization. Composite International Diagnostic Interview, version 1.1. Geneva: World Health Organization; 1993.
15. Ware J. Jr., Kosinski M., Keller S. D. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-33.
16. Robins L. N., Helzer J. E., Croughan J., Ratcliff K. S. National Institute of Mental Health diagnostic interview schedule: its history, characteristics, and validity. Arch Gen Psychiatry 1981; 38: 381.
17. Loranger A. W., Sartorius N., Andreoli A., Berger P., Buchheim P., Channabasavanna S. M. et al. The international personality disorder examination: the World Health Organization/Alcohol, Drug Abuse, and Mental Health Administration international pilot study of personality disorders. Arch Gen Psychiatry 1994; 51: 215.
18. Mills K. L., Teesson M., Ross J., Darke S. The impact of post-traumatic stress disorder on treatment outcomes for heroin dependence. Addiction 2007; 102: 447-54.
19. Twisk J. W. Applied Longitudinal Data Analysis For Epidemiology: a Practical Guide. Cambridge: Cambridge University Press; 2013.
20. Twisk J., de Vente W. Attrition in longitudinal studies: how to deal with missing data. J Clin Epidemiol 2002; 55: 329-37.
21. Grella C. E., Lovinger K. Gender differences in physical and mental health outcomes among an aging cohort of individuals with a history of heroin dependence. Addict Behav 2012; 37: 306-12.
22. Darke S., Mills K. L., Ross J., Williamson A., Havard A., Teesson M. et al. The ageing heroin user: career length, clinical profile and outcomes across 36months. Drug Alcohol Rev 2009; 28: 243-9.
23. Daughters S. B., Braun A. R., Sargeant M. N., Reynolds E. K., Hopko D. R., Blanco C. et al. Effectiveness of a brief behavioral treatment for inner-city illicit drug users with elevated depressive symptoms: the life enhancement treatment for substance use (LETS Act!). J Clin Psychiatry 2008; 69: 122-9.
24. Gossop M., Marsden J., Stewart D., Rolfe A. Treatment retention and 1year outcomes for residential programmes in England. Drug Alcohol Depend 1999; 57: 89-98.
25. Teesson M., Havard A., Ross J., Darke S. Outcomes after detoxification for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Rev 2006; 25: 241-7.
26. Ross J., Teesson M., Darke S., Lynskey M., Ali R., Ritter A. et al. Short-term outcomes for the treatment of heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Addict Disord Their Treat 2006; 5: 133-43.
27. Gossop M., Marsden J., Stewart D., Rolfe A. Reductions in acquisitive crime and drug use after treatment of addiction problems: 1-year follow-up outcomes. Drug Alcohol Depend 2000; 58: 165-72.
28. Chutuape M. A., Jasinski D. R., Fingerhood M. I., Stitzer M. L. One-, three-, and six-month outcomes after brief inpatient opioid detoxification. Am J Drug Alcohol Abuse 2001; 27: 19-44.
29. Johnston S., Salkeld G., Sanderson K., Issakidis C., Teesson M., Buhrich N. Intensive case management: a cost-effectiveness analysis. Aust NZ J Psychiatr 1998; 32: 551-9.